LLA vs. DXRX, AGL, ABDX, VRCI, YGEN, GENI, GDR, PRM, LLAI, and IDHC
Should you be buying LLA.L,0P0001T9GN,0 stock or one of its competitors? The main competitors of LLA.L,0P0001T9GN,0 include Diaceutics (DXRX), ANGLE (AGL), Abingdon Health (ABDX), Verici Dx (VRCI), Yourgene Health (YGEN), GENinCode (GENI), genedrive (GDR), Proteome Sciences (PRM), LungLife AI (LLAI), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
LLA.L,0P0001T9GN,0 (LON:LLA) and Diaceutics (LON:DXRX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, community ranking, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.
LLA.L,0P0001T9GN,0 has a net margin of 0.00% compared to Diaceutics' net margin of -7.37%. Diaceutics' return on equity of -4.19% beat LLA.L,0P0001T9GN,0's return on equity.
Diaceutics has higher revenue and earnings than LLA.L,0P0001T9GN,0. Diaceutics is trading at a lower price-to-earnings ratio than LLA.L,0P0001T9GN,0, indicating that it is currently the more affordable of the two stocks.
5.4% of LLA.L,0P0001T9GN,0 shares are held by institutional investors. Comparatively, 52.3% of Diaceutics shares are held by institutional investors. 34.3% of Diaceutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
LLA.L,0P0001T9GN,0 has a beta of -0.3, suggesting that its share price is 130% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.
Diaceutics has a consensus price target of GBX 160, indicating a potential upside of 19.40%.
In the previous week, Diaceutics had 3 more articles in the media than LLA.L,0P0001T9GN,0. MarketBeat recorded 3 mentions for Diaceutics and 0 mentions for LLA.L,0P0001T9GN,0. LLA.L,0P0001T9GN,0's average media sentiment score of 0.00 beat Diaceutics' score of -0.12 indicating that LLA.L,0P0001T9GN,0 is being referred to more favorably in the media.
Diaceutics received 12 more outperform votes than LLA.L,0P0001T9GN,0 when rated by MarketBeat users.
Summary
Diaceutics beats LLA.L,0P0001T9GN,0 on 11 of the 14 factors compared between the two stocks.
Get LLA.L,0P0001T9GN,0 News Delivered to You Automatically
Sign up to receive the latest news and ratings for LLA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LLA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart
LLA.L,0P0001T9GN,0 Competitors List
Related Companies and Tools
This page (LON:LLA) was last updated on 9/18/2024 by MarketBeat.com Staff